Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$3.69B |
| 2 |
Abbott
ABT
|
+$3.65B |
| 3 |
Qualcomm
QCOM
|
+$3.54B |
| 4 |
Procter & Gamble
PG
|
+$3.42B |
| 5 |
Accenture
ACN
|
+$3.28B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$2.86B |
| 2 |
AbbVie
ABBV
|
+$2.71B |
| 3 |
Valero Energy
VLO
|
+$1.86B |
| 4 |
Lockheed Martin
LMT
|
+$916M |
| 5 |
Halliburton
HAL
|
+$856M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 10.68% |
| 3 | Healthcare | 10.19% |
| 4 | Industrials | 8.63% |
| 5 | Consumer Discretionary | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Cogent Communications
CCOI
$599M
| $14.3M | ﹤0.01% |
760,117
+93,185
| +14% | +$2.05M |
|
1927
Perrigo
PRGO
$1.43B
| $14.3M | ﹤0.01% |
1,333,130
+169,991
| +15% | +$2.2M |
|
1928
Axogen
AXGN
$2.17B
| $14.2M | ﹤0.01% |
429,944
+25,957
| +6% | +$844K |
|
1929
Viridian Therapeutics
VRDN
$2.19B
| $14.2M | ﹤0.01% |
727,937
-21,024
| -3% | -$624K |
|
1930
Stoke Therapeutics
STOK
$1.84B
| $14.2M | ﹤0.01% |
437,175
+26,269
| +6% | +$862K |
|
1931
Golar LNG
GLNG
$4.9B
| $14.2M | ﹤0.01% |
261,631
+18,535
| +8% | +$818K |
|
1932
Descartes Systems
DSGX
$6.16B
| $14.1M | ﹤0.01% |
197,969
+8,436
| +4% | +$623K |
|
1933
Enliven Therapeutics
ELVN
$3.84B
| $14.1M | ﹤0.01% |
360,577
+5,385
| +2% | +$149K |
|
|
SNCY
1934
DELISTED
Sun Country Airlines
SNCY
| $14.1M | ﹤0.01% |
852,582
+32,842
| +4% | +$586K |
|
1935
RPC Inc
RES
$1.22B
| $14.1M | ﹤0.01% |
1,986,150
+167,276
| +9% | +$1.04M |
|
1936
Millicom
TIGO
$15.9B
| $14M | ﹤0.01% |
187,306
-13,318
| -7% | -$873K |
|
1937
IDT Corp
IDT
$1.64B
| $14M | ﹤0.01% |
285,758
-13,960
| -5% | -$690K |
|
1938
Magnite
MGNI
$2.78B
| $14M | ﹤0.01% |
1,180,431
-7,070
| -0.6% | -$94.8K |
|
|
NVO
1939
Novo Nordisk
NVO
$219B
| $14M | ﹤0.01% |
381,264
-20,734
| -5% | -$982K |
|
1940
Freshworks
FRSH
$3.06B
| $14M | ﹤0.01% |
1,743,347
-3,175
| -0.2% | -$29.3K |
|
|
ALMS
1941
Alumis Inc
ALMS
$3.43B
| $14M | ﹤0.01% |
635,389
+131,314
| +26% | +$3.28M |
|
1942
BJ's Restaurants
BJRI
$1.42B
| $14M | ﹤0.01% |
398,313
+13,083
| +3% | +$523K |
|
|
GRAL
1943
GRAIL Inc
GRAL
$2.91B
| $14M | ﹤0.01% |
269,953
-874
| -0.3% | -$67.7K |
|
1944
LSB Industries
LXU
$828M
| $13.9M | ﹤0.01% |
929,851
-35,906
| -4% | -$409K |
|
1945
Vermilion Energy
VET
$1.64B
| $13.8M | ﹤0.01% |
1,008,072
+64,172
| +7% | +$680K |
|
1946
Coty
COTY
$2.35B
| $13.8M | ﹤0.01% |
6,877,507
+827,480
| +14% | +$2.22M |
|
1947
John B. Sanfilippo & Son
JBSS
$983M
| $13.8M | ﹤0.01% |
174,003
-7,031
| -4% | -$541K |
|
1948
NuScale Power
SMR
$2.87B
| $13.8M | ﹤0.01% |
1,268,619
+66,851
| +6% | +$1.02M |
|
1949
QuidelOrtho
QDEL
$1.16B
| $13.6M | ﹤0.01% |
830,059
-18,119
| -2% | -$445K |
|
1950
E.W. Scripps
SSP
$279M
| $13.6M | ﹤0.01% |
3,662,774
-1,059,543
| -22% | -$3.91M |
|
Similar funds
Charles Schwab's Q1 2026 Portfolio in Review
As of Q1 2026, Charles Schwab held 3,535 positions worth $654B, up 1.7% from $644B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Charles Schwab deployed $21.4B of net new capital in Q1 2026, opening 79 new positions and adding to 1,903 existing holdings. Its largest new stake was JPMorgan Income ETF: 8,679,689 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Cisco, an estimated $2.86B trimmed.
- Charles Schwab's largest Q1 2026 buy was JPMorgan Income ETF: 8,679,689 shares worth $400M.
- Charles Schwab added most to UnitedHealth in Q1 2026, an estimated $3.69B increase.
- Charles Schwab's biggest Q1 2026 reduction was Cisco, cutting an estimated $2.86B.
- Charles Schwab fully exited Comerica in Q1 2026, selling an estimated $412M.
- Charles Schwab's ten largest holdings make up 22% of its $654B portfolio in Q1 2026.
- Charles Schwab opened 79 new positions and closed 80 in Q1 2026.
- Charles Schwab's portfolio value rose 1.7% quarter-over-quarter to $654B.
Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.